Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicentre Double Blind Randomised Trial of Celecoxib Versus Placebo in Primary Breast Cancer Patients

NCT02429427 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02429427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02429427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicentre Double Blind Randomised Trial of Celecoxib Versus Placebo in Primary Breast Cancer Patients
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
March 31, 2019
Enrollment
2,639 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer